Literature DB >> 8626118

Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature.

A Goodman1, L R Zukerberg, L W Rice, A F Fuller, R H Young, R E Scully.   

Abstract

BACKGROUND: Endometrial squamous cell carcinoma is extremely rare, with only 56 cases reported in the literature.
METHODS: Six cases of endometrial squamous cell carcinoma were found in a review of 1182 cases of uterine corpus cancer treated at the Massachusetts General Hospital from 1975 to 1993. Two additional cases were seen in pathological consultation. The clinicopathological features of these 8 cases and the 56 reported cases were analyzed.
RESULTS: The average age of the patients was 67 years; almost all of them were postmenopausal. The most frequent presenting symptom was vaginal bleeding. Chronic pyometra and nulliparity were predisposing factors. The average duration of symptoms before diagnosis was 11.5 months. Total abdominal hysterectomy with bilateral salpingo-oophorectomy was the primary treatment in 58 patients. Eighty percent of the patients with Stage I tumors survived; the median follow-up time was 32 months. The survival rate for patients with Stage III tumors was only 20%, and all 6 patients with Stage IV disease died.
CONCLUSIONS: The preoperative diagnosis of endometrial squamous cell carcinoma may be difficult, since curettage specimens may show only highly differentiated squamous epithelium. The strong relationship between tumor stage and survival suggests that early diagnosis and treatment are imperative.

Entities:  

Mesh:

Year:  1996        PMID: 8626118     DOI: 10.1006/gyno.1996.0096

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Pyometra and recurrent prolapse after Le Fort colpocleisis.

Authors:  Ted M Roth
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-26

Review 2.  Superficial spreading cervical squamous cell carcinoma in situ involving the endometrium: a case report and review of the literature.

Authors:  Javier Martín-Vallejo; Juan B Laforga; Patricia Molina-Bellido; Pedro A Clemente-Pérez
Journal:  J Med Case Rep       Date:  2022-05-20

3.  Primary endometrial squamous cell carcinoma: a case report and review of relevant literature on korean women.

Authors:  Sung Jong Lee; Hyun Joo Choi
Journal:  Korean J Pathol       Date:  2012-08-23

4.  Primary pure squamous cell carcinoma of the endometrium: a case report.

Authors:  Tadashi Terada; Kazuhiro Tateoka
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

Review 5.  Primary squamous cell carcinoma of endometrium: case report and literature review.

Authors:  Fatima Zahra Farhane; Zineb Alami; Touria Bouhafa; Abderrahmane Elmazghi; Khalid Hassouni
Journal:  Pan Afr Med J       Date:  2018-05-04

Review 6.  Primary squamous cell carcinoma of endometrium: case report and literature review.

Authors:  Fatima Zahra Farhane; Zineb Alami; Touria Bouhafa; Abderrahmane Elmazghi; Khalid Hassouni
Journal:  Pan Afr Med J       Date:  2018-07-16

7.  Primary Squamous Cell Carcinoma of the Upper Genital Tract: Utility of p16(INK4a) Expression and HPV DNA Status in its Differential Diagnosis from Extended Cervical Squamous Cell Carcinoma.

Authors:  Su Hyun Yoo; Eun-Mi Son; Chang Okh Sung; Kyu-Rae Kim
Journal:  Korean J Pathol       Date:  2013-12-24

8.  Primary squamous cell carcinoma of the endometrium in a woman of perimenopausal age: A case report.

Authors:  Chao Zhang; Hongyan Zhang; Linqing Yang; Yunfei Wang; Xiaoyu Li; Jinfeng Guo; Jing Xu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

9.  Primary squamous cell carcinoma of the endometrium in a woman of reproductive age: a rare case report.

Authors:  Qi Wu; Zhaoping Chu; Hua Han; Suning Bai; Wenfei Wu; Xiying Li; Shixuan Wei; Ping Yan
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

Review 10.  Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.

Authors:  Hiroshi Yoshida; Kouya Shiraishi; Tomoyasu Kato
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.